Elevated plasma and urinary endothelin-I levels in human salt-sensitive hypertension

Clinical Science

Volumn 93, Issue 1, 1997, Pages 35-41

  Ferri, Claudio ^a   Bellini, Cesare ^b   Desideri, Giovambattista ^a   Mazzocchi, Clarita ^b   De Siati, Luca ^a   Santucci, Anna ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cardiovascular system; Endothelins; Endothelium; Hypertension; Sodium

Indexed keywords

ALBUMIN; CREATININE; ENDOTHELIN 1; SODIUM CHLORIDE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SALT INTAKE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 0030846498     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930035     Document Type: Article

References (34)

1. + intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 1982; 21: 371-8.
2. Ferri C, Bellini C, Carlomagno A, Desideri G, Santucci A. Active kallikrein response to changes in sodium chloride intake in essential hypertensive patients. J Am Soc Nephrol 1996; 7: 443-53.
3. Bigazzi R, Bianchi S, Baldari G, Campese VM. Clustering of cardiovascular risk factors in salt sensitive patients with essential hypertension: role of insulin. Am J Hypertens 1996; 9: 24-32.
4. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994; 23: 195-9.
5. Weder AB. Membrane sodium transport and salt sensitivity of blood pressure. Hypertension 1991; 17 (Suppl 1): 1-74-1-80.
6. Ferri C, Bellini C, Carlomagno A, Perrone A, Santucci A. Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int 1994; 46: 780-8.
7. Pessina AC, Rossi GP. Hypertension as a mechanism of atherosclerosis: focus on hemodynamic and endothelial factors. High Blood Press 1993; 2: 259-70.
8. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 1988; 332: 411-15.
9. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR. Elevated plasma endothelin-1 in diabetes mellitus. Diabetologia 1990; 33: 306-10.
10. Ferri C, Bellini C, Desideri G, et al. Plasma endothelin-1 levels in obese and non-obese hypertensive patients. Diabetes 1995; 44: 431-6.
11. Ferri C, Bellini C, Desideri G, Di Francesco L, De Mattia G, Santucci A. Dysfonction endotheliale dans l'hypertension arterielle sensible au sel. Arch Mal Coeur Vais 1996; 86: 971-4.
12. Joint National Committee on detection, evaluation, and treatment of high blood pressure. The fifth report (JNCV). Arch Int Med 1993; 153: 154-83.
13. Polderman KH, Stehouwer CDA, van Kamp GJ, Dekker GA, Verheug FWA, Gooren LJG. Influence of sex hormones on plasma levels of endothelin. Ann Intern Med 1993; 118: 429-32.
14. Lerman A, Edwards BS, Hallett JW, Heiblein DM, Sondberg SM, Burnett Jr JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Eng J Med 1991;325:997-1001.
15. Haak T, Jungmann E, Raab C, Usadel KH. Elevated endothelin-1 levels after cigarette smoking. Metabolism 1994; 43: 267-9.
16. Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 1992; 85: 510-17.
17. Wagner OF, Nowotny P, Vierhapper H, Waldhäusl W. Plasma concentrations of endothelin in man: artero-venous differences and release during venous stasis. Eur J Clin Invest 1990; 220: 502-5.
18. Ferri C, Pittoni V, Piccoli A, et al. Insulin stimulates endothelin-1 secretion from human endothermal cells and modulates its circulating levels in vitro. J Clin Endocrinol Metab 1995; 80: 829-35.
19. Bevan JA. Flow regulation of the vascular tone. Its sensitivity to changes in sodium and calcium. Hypertension 1993; 22: 273-81.
20. Panza JA, Quyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
21. Properzi G, Terenghi G, Gu XH, et al. Early increase precedes a depletion of endothelin-1 but not of von Willebrand factor in the skin of diabetics: a quantitative immunohistochemical study. J Pathol 1994; 5: 211-18.
22. Davi' G, Giammarresi C, Vigneri S, et al. Demonstration of rickettsia conorii-induced coagulative and platelet activation in vivo in patients with mediterranean spotted fever. Thromb Haemost 1995; 74: 631-4.
23. Vermes I, Spooren PFMJ, Kalsbeek-Batenburg EM. In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia 1993; 36: 472-3.
24. Morise T, Tanuchi Y, Kawano M, Koni J, Takeda R. Increased plasma levels of immunoreactivity endothelin-1 and von Willebrand factor in NIDDM patients. Diabetes Care 1995; 18: 87-9.
25. Jensen T, Borch-Johnson K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987; 30: 144-8.
26. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes mellitus. N Eng J Med 1984; 310: 356-60.
27. Bulpitt CJ, Beilin LJ, Clifton P. Risk factors for death in treated hypertensive patients. Lancet 1979; 11: 134-7.
28. Stehouwer CDA, Nauta JIP, Zeldenrust GC, Hackeng WHL, Donker AJM, Den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23.
29. Viberti GC, Hill RD, Jarrett RD, et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430-2.
30. Abassi ZA, Tate J, Colomb E, Klein H, Keiser HR. Role of neutral endopeptidase in metabolism of endothelin. Hypertension 1992; 20: 89-95.
31. Hoffman A, Grossman E, Goldstein DS, Gill JR, Keiser HR. Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int 1994; 45: 556-60.
32. Kohan DE, Hughes AK. Autocrine role of endothelin in rat IMCD: inhibition of AVP-induced cAMP accumulation. Am J Physiol 1993; 265: F126-9.
33. Tomita K, Nonoguchi H, Terada Y. Effects of ET-1 on water and chloride transport in cortical collecting ducts of the rat. Am J Physiol 1993; 264: F690-6.
34. Abassi ZA, Klein H, Golomb E, Keiser HR. Urinary endothelin: a possible biological marker of renal damage. Am J Hypertens 1993; 6: 1046-54.